Reference: G0800401 Abstract: n.a PROJECT DETAILS beginning: 2008. end: 2012. Country of research: United Kingdom Counry of funding source: United Kingdom Funding organization: Medical Research Council Financing: NATIONAL FUNDINGS – 2 251 319 € hyperlink
Reference: 1F31MH078678n.a.1A2 Abstract: MeCP2 is a transcriptional repressor critical for normal neurological function. Rett syndrome (RTT) is a progressive neurodevelopmental disease caused by predominantly loss of function mutations in the X-linked gene encoding the transcriptional repressor, methyl-CpG-binding protein 2 (MECP2) genes. Classic RTT patients exhibit a spectrum of neurological phenotypes that include tremors, ataxia, seizures, … Read more
Reference: ANRn.a.8-BIOTn.a.020 Abstract: Rett syndrome (RS) is a severe neurological disorder caused by a mutation in the MECP2 gene transcriptional repressor.�SR girls develop normally until 6-18 months later, they suffer neurological symptoms and severe respiratory ?irregularities.�So far no treatment is available.�Previously, using a mouse model of SR, we have shown that disruption of the respiratory … Read more
Reference: G0800026 Abstract: n.a PROJECT DETAILS beginning: 2008. end: 2012. Country of research: United Kingdom Counry of funding source: United Kingdom Funding organization: Medical Research Council Financing: NATIONAL FUNDINGS – 954 998 € hyperlink
Reference: ETF6225ﾠ Abstract: The biochemical markers that influence the growth of children have not been investigated much. The main goal of the present study is to investigate the relationships between novel peptide hormone ghrelin and anthropometrical characteristics, body composition, physical activity and aerobic working capacity, also to examine the adaptation to aerobic work and weight … Read more
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
